Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 101 Records) |
| Query Trace: Adenocarcinoma and Brca1[original query] |
|---|
| Germline DNA damage repair gene mutations in pancreatic cancer patients with personal/family histories of pancreas/breast/ovarian/prostate cancer in a Japanese population. Annals of gastroenterological surgery 2021 11 5 (6): 853-864. Hata Tatsuo, Mizuma Masamichi, Motoi Fuyuhiko, Ishida Masaharu, Ohtsuka Hideo, Nakagawa Kei, Morikawa Takanori, Furukawa Toru, Unno Michia |
| Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma. Molecular diagnosis & therapy 2022 9 26 (6): 645-653. Zheng-Lin Binbin, Rainone Michael, Varghese Anna M, Yu Kenneth H, Park Wungki, Berger Michael, Mehine Miika, Chou Joanne, Capanu Marinela, Mandelker Diana, Stadler Zsofia K, Birsoy Ozge, Jairam Sowmya, Yang Ciyu, Li Yirong, Wong Donna, Benhamida Jamal K, Ladanyi Marc, Zhang Liying, O'Reilly Eileen |
| Characterization of lung cancers in patients with BRCA germline variants: A multicenter series. Lung cancer (Amsterdam, Netherlands) 2022 9 173 67-70. Sanchis-Borja Mateo, Fallet Vincent, Fabre Elisabeth, Wislez Marie, Culine Stéphane, Zalcman Gérard, Spano Jean-Philippe, Buffet Nathalie Chabbert, Coulet Florence, Benusiglio Patrick R, Cadranel Jacqu |
| Comprehensive Analysis of Genomic Alterations in Hepatoid Adenocarcinoma of the Stomach and Identification of Clinically Actionable Alterations. Cancers 2022 08 14 (16): . Zhao Rongjie, Li Hongshen, Ge Weiting, Zhu Xiuming, Zhu Liang, Wan Xiangbo, Wang Guanglan, Pan Hongming, Lu Jie, Han Weido |
| A Genome-First Approach to Estimate Prevalence of Germline Pathogenic Variants and Risk of Pancreatic Cancer in Select Cancer Susceptibility Genes. Cancers 2022 Jul 14 (13): . Astiazaran-Symonds Esteban, Kim Jung, Haley Jeremy S, Kim Sun Young, Rao H Shanker, Genetics Center Regeneron, Carey David J, Stewart Douglas R, Goldstein Alisa |
| Risk of pancreatic ductal adenocarcinoma associated with carriage of BRCA1 and/or BRCA2 mutation: A systematic review and meta-analysis. Journal of surgical oncology 2022 Jun . McGarry Jennifer L, Creavin Ben, Kelly Michael E, Gallagher Tom |
| Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience. JCO precision oncology 2022 6 6 e2100289. Gerratana Lorenzo, Movarek Michael, Wehbe Firas, Katam Neelima, Mahalingam Devalingam, Donahue Jeannine, Shah Ami, Chae Young K, Mulcahy Mary, Tsarwhas Dean, Villaflor Victoria, Kalyan Aparna, Hussein Maha, Patel Jyoti, Chandra Sunandana, Platanias Leonidas C, Gradishar William, Cristofanilli Massimo, Behdad Am |
| Genetic testing to guide screening for pancreatic ductal adenocarcinoma: Results of a microsimulation model. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2022 6 22 (6): 760-769. Peters Mary Linton B, Eckel Andrew, Lietz Anna, Seguin Claudia, Mueller Peter, Hur Chin, Pandharipande Pari |
| CNV assessments associated with outcome distinctions for adult and pediatric cancers: Loss of BRCA1 in neuroblastoma associates with a lower survival probability. Gene 2022 6 836 146673. Varkhedi Mallika, Barker Vayda R, Eakins Rachel A, Blanck Geor |
| Response in BRCA1 mutation carrier with metastatic pancreatic adenocarcinoma treated with FOLFIRINOX. BMJ case reports 2022 4 15 (4): . Campoverde Leticia Estefania, Batalini Felipe, Bulushi Yarab, Bullock Andr |
| Spectrum of BRCA1/2 Mutations in Romanian Breast and Ovarian Cancer Patients. International journal of environmental research and public health 2022 4 19 (7): . Vidra Radu, Ciuleanu Tudor Eliade, Neme? Adina, Pascu Oana, Heroiu Ana Maria, Antone Nicoleta, Vidrean Andreea Iulia, Oprean Cristina Marinela, Pop Laura Ancuta, Berindan-Neagoe Ioana, Eniu Rares, Eniu Alexand |
| A BRCA1 Splice Site Variant Responsible for Familial Ovarian Cancer in a Han-Chinese Family. Current medical science 2022 3 42 (3): 666-672. Hu Peng-Zhi, Chen Xiang-Yu, Xiong Wei, Yang Zhi-Jian, Li Xiao-Rong, Deng Wen-Zhi, Gong Li-Na, Deng Hao, Yuan La-M |
| Reflex Testing for Germline BRCA1, BRCA2, PALB2, and ATM Mutations in Pancreatic Cancer: Mutation Prevalence and Clinical Outcomes From Two Canadian Research Registries. JCO precision oncology 2022 2 2 1-16. Smith Alyssa L, Wong Cavin, Cuggia Adeline, Borgida Ayelet, Holter Spring, Hall Anita, Connor Ashton A, Bascuñana Claire, Asselah Jamil, Bouganim Nathaniel, Poulin Véronique, Jolivet Jacques, Vafiadis Petro, Le Philippe, Martel Guillaume, Lemay Frédéric, Beaudoin Annie, Rafatzand Khashayar, Chaudhury Prosanto, Barkun Jeffrey, Metrakos Peter, Marcus Victoria, Omeroglu Atilla, Chong George, Akbari Mohammad R, Foulkes William D, Gallinger Steven, Zogopoulos Geor |
| Homologous Recombination Deficiency in Patients With Pancreatic Ductal Adenocarcinoma and Response to Chemotherapy. JCO precision oncology 2022 2 2 1-11. Shahda Safi, Timms Kirsten M, Ibrahim Ashley A, Reid Julia E, Cramer Harvey M, Radovich Milan, Ibrahim Sulfikar, Allen Brian, O'Neil Bert |
| Retrospective Survival Analysis of Patients With Advanced Pancreatic Ductal Adenocarcinoma and Germline BRCA or PALB2 Mutations. JCO precision oncology 2022 2 2 1-9. Reiss Kim A, Yu Shun, Judy Renae, Symecko Heather, Nathanson Katherine L, Domchek Susan |
| Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation. Genes 2022 2 13 (2): . Vietri Maria Teresa, D'Elia Giovanna, Caliendo Gemma, Albanese Luisa, Signoriello Giuseppe, Napoli Claudio, Molinari Anna Mar |
| Retrospective Survival Analysis of Patients With Resected Pancreatic Ductal Adenocarcinoma and a Germline BRCA or PALB2 Mutation. JCO precision oncology 2022 2 3 1-11. Yu Shun, Agarwal Parul, Mamtani Ronac, Symecko Heather, Spielman Kelsey, O'Hara Mark, O'Dwyer Peter J, Schneider Charles, Teitelbaum Ursina, Nathanson Katherine L, Domchek Susan M, Reiss Kim |
| Potential value of the homologous recombination deficiency signature we developed in the prognosis and drug sensitivity of gastric cancer. Frontiers in genetics 2022 12 13 1026871. Wu Xin, Wang Qiong, Liu Peifa, Sun Linde, Wang |
| Case report: olaparib use in metastatic lung adenocarcinoma with BRCA2 pathogenic variant. Cold Spring Harbor molecular case studies 2022 12 8 (7): . Soon Jian Hao Jonathan, Hoai Chan Sock, Weng Daniel Tan Shao, Ngeow Joanne, Chiang Jianba |
| The germline mutational landscape of genitourinary cancers and its indication for prognosis and risk. BMC urology 2022 11 22 (1): 196. Yang Yong, Zhang Guoying, Hu Chen, Luo Wei, Jiang Haiyang, Liu Shaoyou, Yang Ho |
| Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China. JAMA network open 2022 02 5 (2): e2148721. Yin Lingdi, Wei Jishu, Lu Zipeng, Huang Shimeng, Gao Hao, Chen Jianmin, Guo Feng, Tu Min, Xiao Bin, Xi Chunhua, Zhang Kai, Li Qiang, Wu Junli, Gao Wentao, Jiang Kuirong, Yu Jun, Miao |
| Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable Mutations. Biomedicines 2023 9 11 (9): . Anthony Tarabay, Alice Boileve, Cristina Smolenschi, Leony Antoun, Marine Valery, Alina Fuerea, Audrey Perret, Pascal Burtin, Simona Cosconea, Hichem Belkhodja, David Malka, Valérie Boige, Antoine Hollebecque, Michel Ducre |
| Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficien cy in Pancreatic Acinar Cell Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 8 JCO2300561. Diana Mandelker, Antonio Marra, Binbin Zheng-Lin, Pier Selenica, Juan Blanco-Heredia, Yingjie Zhu, Andrea Gazzo, Donna Wong, Zarina Yelskaya, Vikas Rai, Joshua Somar, Silvana Ostafi, Nikita Mehta, Ciyu Yang, Yirong Li, David N Brown, Edaise M da Silva, Xin Pei, Irina Linkov, Panieh Terraf, Maksym Misyura, Ozge Ceyhan-Birsoy, Marc Ladanyi, Michael Berger, Fresia Pareja, Zsofia Stadler, Kenneth Offit, Nadeem Riaz, Wungki Park, Joanne Chou, Marinela Capanu, Maria Koehler, Ezra Rosen, Eileen M O'Reilly, Jorge S Reis-Fil |
| Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants. JAMA oncology 2023 5 . Xuan Chen, Margaret A Meyer, Jennifer L Kemppainen, Masayasu Horibe, Shruti Chandra, Shounak Majumder, Gloria M Petersen, Kari G Ra |
| Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan. Journal of gastroenterology 2023 4 . Sakakida Tomoki, Ishikawa Takeshi, Doi Toshifumi, Morita Ryuichi, Kataoka Seita, Miyake Hayato, Yamaguchi Kanji, Moriguchi Michihisa, Sogame Yoshio, Yasuda Hiroaki, Iwasaku Masahiro, Konishi Hideyuki, Takayama Koichi, Itoh Yoshi |
| Prevalence and Risk Factors of Germline Pathogenic Variants in Pancreatic Ductal Adenocarcinoma. Cancer research and treatment 2023 4 . Ryu Kum Hei, Park Sunhwa, Chun Jung Won, Cho Eunhae, Choi Jongmun, Lee Dong-Eun, Shim Hyoeun, Kim Yun-Hee, Han Sung-Sik, Park Sang-Jae, Woo Sang Myung, Kong Sun-You |
| Somatic Variants in DNA Damage Response Genes in Ovarian Cancer Patients Using Whole-exome Sequencing. Anticancer research 2023 4 43 (5): 1891-1900. Joanna Lopacinska-Joergensen, Douglas V N P Oliveira, Tim Svenstrup Poulsen, Claus K Hoegdall, Estrid V Hoegda |
| Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications. Cancer medicine 2023 3 . Zhao Zhiming, Li Xiaomo, Wang Fei, Xu Yong, Liu Si, Han Quanli, Yang Zhiying, Huang Weiwei, Yin Zhuzeng, Liu Qu, Tan Haidong, Ma Tonghui, Si Shuang, Huang Jia, Yuan Hongling, Li Wei, Liu Ro |
| Germline mutations in homologous recombination repair genes among Chinese pancreatic ductal adenocarcinoma patients detected using next-generation sequencing. Molecular genetics & genomic medicine 2023 3 e2170. Jiang Huiqin, Huang Fei, Chen Xinning, Zhang Li, Shen Minna, Pan Baishen, Wang Beili, Guo W |
| The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants. Cancer 2023 10 . Ido Laish, Menachem Schechter, Alain Dancour, Sari Lieberman, Zohar Levi, Yael Goldberg, Inbal Kedar, Erez Hasnis, Elizabeth Half, Gili Reznick Levi, Lior Katz, Elez D Vainer, Dor Genzel, Maya Aharoni, Rakefet Chen-Shtoyerman, Naim Abu-Freha, Maria Raitses-Gurevich, Talia Golan, Rinat Bernstein-Molho, Merav Ben Yehoyada, Nathan Gluck, Guy Rosn |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 01, 2023
- Content source: